| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 12/31/2003 | CA2489813A1 Use of thio-oxindole derivatives in treatment of hormone-related conditions |
| 12/31/2003 | CA2487266A1 Benzimidazole compounds and their use as estrogen agonists/antagonists |
| 12/31/2003 | CA2485537A1 Novel compounds, their use and preparation |
| 12/31/2003 | CA2464539A1 Enhancing treatment of mdr cancer with adenosine a3 antagonists |
| 12/30/2003 | US6670493 Methods and compositions for treating diseases due to androgen deficiency with glucocorticoid receptor antagonist compounds and new compounds |
| 12/30/2003 | US6670466 Human endogenous retrovirus in breast cancer |
| 12/30/2003 | US6670376 Aryl aniline β2 adrenergic receptor agonists |
| 12/30/2003 | US6670372 Aryl ether substituted imidazoquinolines |
| 12/30/2003 | US6670366 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction |
| 12/30/2003 | US6670359 Such as (S)-N-(5-(4-Methylpiperazin-1-yl)-3,4-dihydro-2H-1-benzopyran-3-yl)-4 -morpholinobenzamide for treatment of mood/anxiety/eating disorders |
| 12/30/2003 | US6670352 Androgenic steroid compounds and a method of making and using the same |
| 12/30/2003 | US6670350 Method of administering dienogest in high dosages to reduce the body of the breast and pharmaceutical composition for same |
| 12/30/2003 | US6670346 Treatment and/or inhibition of the development of osteoporosis, breast cancer, hypercholesterolemia, hyperlipidemia or atherosclerosis in susceptible warm-blooded animals including humans, administering selective estrogen |
| 12/30/2003 | US6669966 Topically applying oxides of bismuth, cobalt, copper, iron, manganese or praseodymium, as ointments or on bandages to improve neovascularization of injuries or skin disorders |
| 12/30/2003 | US6669941 Administering drugs comprising tumor necrosis factor adrenergic blocking agents conjugated to immunoglobulins for the prophylaxis of rheumatoid arthritis, multiple sclerosis or diabetes |
| 12/29/2003 | WO2004002469A1 Isoflavone concentrate and method for production thereof |
| 12/29/2003 | CA2448513A1 Isoflavone concentrates, as well as methods for their production |
| 12/25/2003 | US20030237101 Stem cell factor; modulation of gene expression |
| 12/25/2003 | US20030236309 Novel formate salt of O-desmethyl-venlafaxine |
| 12/25/2003 | US20030236284 Topical applying |
| 12/25/2003 | US20030236272 Method and composition for treatment of diabetes, hypertension, chronic heart failure and fluid retentive states |
| 12/25/2003 | US20030236263 Chemical compounds |
| 12/25/2003 | US20030236262 Dietetics; antidiabetic agents; sexual disorders |
| 12/25/2003 | US20030236258 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 12/25/2003 | US20030236230 Comprises 4-substituted piperidine ring linked to a substituted or unsubstituted hydrocarbyl ring; for controlling weight gain in a human or higher mammal |
| 12/25/2003 | US20030236213 Compounds useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders |
| 12/25/2003 | US20030236212 Compounds useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders |
| 12/25/2003 | US20030236193 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 12/25/2003 | US20030236185 Novel two Gonadotropin releasing hormones and a method to isolate the same |
| 12/25/2003 | US20030235900 Anticancer agents |
| 12/25/2003 | US20030235625 Gels comprising mixtures of bismuth subnitrate and aluminium stearate, used as barriers for sealing nipples of cattle; prevention of mastitis |
| 12/25/2003 | US20030235617 Pharmaceutical dosage form for mucosal delivery |
| 12/25/2003 | US20030235588 Thioredoxin (TRX); administering histone deacetylase inhibitors such as trichostatin A; for treating inflammation |
| 12/25/2003 | US20030235536 Administering an aerosol, a conjugate of a therapeutic agent and an FcRn binding partner, for treating resipiratory system disorders, drug delivery of an antibody, immunizing vaccines |
| 12/24/2003 | WO2003106707A1 Method for detecting increased susceptibility to tumours |
| 12/24/2003 | WO2003106669A1 Purified pkb ser 473 kinase and uses thereof |
| 12/24/2003 | WO2003106662A1 In vitro fertilisation |
| 12/24/2003 | WO2003106660A2 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 12/24/2003 | WO2003106462A1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 12/24/2003 | WO2003106452A2 Antagonists of melanin concentrating hormone receptor |
| 12/24/2003 | WO2003106446A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use |
| 12/24/2003 | WO2003106444A1 N,n-disubstituted diazocycloalkanes useful for the treatment of cns disorders due to serotonergic dysfunction |
| 12/24/2003 | WO2003106441A1 Pharmaceutical salts of reboxetine |
| 12/24/2003 | WO2003106416A2 Chemical process |
| 12/24/2003 | WO2003106401A1 N-bridged selective androgen receptor modulators and methods of use thereof |
| 12/24/2003 | WO2003106381A2 Human adam-10 inhibitors |
| 12/24/2003 | WO2003105900A1 Regulation of secretory phospholipase a2 group iia |
| 12/24/2003 | WO2003105825A1 Use of hydroxyeicosatetraenoic acid compounds to treat vaginal dryness |
| 12/24/2003 | WO2003105815A1 Combination of pde-v inhibitors and nk1 antagonists for the treatment of depression |
| 12/24/2003 | WO2003105800A2 Film-shaped mucoadhesive administration form for administering cannabis active ingredients |
| 12/24/2003 | WO2003082807A3 Amino acids with affinity for the alpha-2-delta-protein |
| 12/24/2003 | WO2003072558A3 Arylsulfone derivatives |
| 12/24/2003 | WO2003070182A3 Sodium channel blockers |
| 12/24/2003 | WO2003068760A3 Compounds possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders |
| 12/24/2003 | WO2003062236A8 2-(PYRIDIN-2-YLAMINO)-PYRIDO[2,3d]PYRIMIDIN-7-ONES |
| 12/24/2003 | WO2003006491A3 Peptide-based compounds for targeting intergin receptors |
| 12/24/2003 | WO2002074241A3 Method of delaying ejaculation |
| 12/24/2003 | WO2002068548A8 Use of erss-selective ligands for regulating fertility and compounds useful therefore |
| 12/24/2003 | CN1463191A Low hygroscopic aripiprazole drug substance and processes for prepn. thereof |
| 12/24/2003 | CN1462618A Fibrauretine in dosage form of decentralization tablet |
| 12/24/2003 | CN1131868C 作为药物的三环△3－哌啶 As a tricyclic drug △ 3- piperidine |
| 12/24/2003 | CN1131856C 作为黄体酮受体调节剂的环硫代氨基甲酸酯衍生物 As cyclic thiocarbamate derivative of progesterone receptor modulators |
| 12/24/2003 | CA2529724A1 In vitro fertilisation |
| 12/24/2003 | CA2489791A1 Combinations of pde-v inhibitors and nk1 antagonists for the treatment of anxiety or depression |
| 12/24/2003 | CA2489764A1 Method for detecting increased susceptibility to tumours |
| 12/24/2003 | CA2489648A1 Chemical process |
| 12/24/2003 | CA2489466A1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 12/24/2003 | CA2489450A1 N,n-disubstituted diazocycloalkanes useful for the treatment of cns disorders due to serotonergic dysfunction |
| 12/24/2003 | CA2489252A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use |
| 12/24/2003 | CA2489182A1 N-bridged selective androgen receptor modulators and methods of use thereof |
| 12/24/2003 | CA2489106A1 Film-shaped mucoadhesive administration form for administering cannabis active ingredients |
| 12/24/2003 | CA2488708A1 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 12/24/2003 | CA2485346A1 Human adam-10 inhibitors |
| 12/23/2003 | US6667339 Contraceptive |
| 12/23/2003 | US6667313 8-substituted-6-triflouromethyl-9-pyrido [3,2-G] quinoline compounds as androgen receptor modulators |
| 12/23/2003 | US6667304 Affinity for melatonin receptors; sleep disorders; N-(2-(2-methoxy-6H-pyrido(2',3':4,5)pyrrolo(2,1-a)isoindol-11 -yl)ethyl)acetamide; N-(2-(3-methoxy-6,7,8,9-tetrahydropyrido (3,2-b)indolizin-5-yl) ethyl)acetamide |
| 12/23/2003 | US6667301 Therapy for muscular disorders, urogenital disorders, gastrointestinal disorders, respiratory system disorders |
| 12/23/2003 | US6667291 Endometrial Steroid Binding Protein II activity; endometrial and breast cancers |
| 12/23/2003 | US6667041 Use of neurotoxin therapy for treatment of urologic and related disorders |
| 12/18/2003 | WO2003104260A2 Pharmaceutical formulation |
| 12/18/2003 | WO2003104255A2 Substituted 2-cyclohexyl-4-phenyl-1h-imidazole derivatives |
| 12/18/2003 | WO2003104253A2 9-alpha-substituted estratrienes as selectively active estrogen |
| 12/18/2003 | WO2003104236A1 Calcitonin gene related peptide receptor antagonists |
| 12/18/2003 | WO2003104229A1 Novel fused imidazole derivative |
| 12/18/2003 | WO2003104223A1 Pyrazole-derivatives as p38 kinase inhibitors |
| 12/18/2003 | WO2003104203A1 Therapeutic molecules and methods-1 |
| 12/18/2003 | WO2003103770A2 Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method |
| 12/18/2003 | WO2003103725A1 Compositions and methods for the diagnosis and treatment of tumor |
| 12/18/2003 | WO2003103695A1 Novel therapeutic use of polypodium extracts |
| 12/18/2003 | WO2003103682A1 Compositions for cancer therapy saponins or sapogenins |
| 12/18/2003 | WO2003103665A1 Antiallergic |
| 12/18/2003 | WO2003103649A1 Method for the inhibition of atrophy or for treatment or prevention of atrophy-related symptoms in women |
| 12/18/2003 | WO2003103604A2 Gamma lactams as prostaglandin agonists and use thereof |
| 12/18/2003 | WO2003103603A2 Novel formate salt of o-desmethyl-venlafaxine |
| 12/18/2003 | WO2003074449A3 Multi-substitued selective androgen receptor modulators and methods of use thereof |
| 12/18/2003 | WO2003057159A3 Psoriasin expression by breast epithelial cells |
| 12/18/2003 | WO2003051917A3 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control |
| 12/18/2003 | WO2003050108A8 Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer |
| 12/18/2003 | WO2003027234A3 Small organic molecule regulators of cell proliferation |
| 12/18/2003 | WO2003022303A3 Use of hcg and lh in controlled ovarian hyperstimulation |